Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes

被引:26
|
作者
Claessens, Laura A. [1 ]
Wesselius, Joris [1 ]
van Lummel, Menno [1 ]
Laban, Sandra [1 ]
Mulder, Flip [2 ]
Mul, Dick [3 ]
Nikolic, Tanja [1 ]
Aanstoot, Henk-Jan [3 ]
Koeleman, Bobby P. C. [2 ]
Roep, Bart O. [1 ,4 ]
机构
[1] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands
[3] Diabeter, Ctr Pediat & Adolescent Diabet Care & Res, Rotterdam, Netherlands
[4] City Hope Natl Med Ctr, Dept Diabet Immunol, Diabet & Metab Res Inst, Beckman Res Inst,Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
关键词
Autoimmune disease; Autoreactive T cells; Disease endotypes; Disease heterogeneity; Epitope spreading; Immunotherapy; Islet autoantigen; Patient heterogeneity; Personalised medicine; Precision medicine; GENOME-WIDE ASSOCIATION; RISK SCORE; SUSCEPTIBILITY; CELL; DISEASE; AUTOANTIBODIES; METAANALYSIS; PREDICTION; CHILDREN; LOCI;
D O I
10.1007/s00125-019-05032-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Heterogeneity in individuals with type 1 diabetes has become more generally appreciated, but has not yet been extensively and systematically characterised. Here, we aimed to characterise type 1 diabetes heterogeneity by creating immunological, genetic and clinical profiles for individuals with juvenile-onset type 1 diabetes in a cross-sectional study. Methods Participants were HLA-genotyped to determine HLA-DR-DQ risk, and SNP-genotyped to generate a non-HLA genetic risk score (GRS) based on 93 type 1 diabetes-associated SNP variants outside the MHC region. Islet autoimmunity was assessed as T cell proliferation upon stimulation with the beta cell antigens GAD65, islet antigen-2 (IA-2), preproinsulin (PPI) and defective ribosomal product of the insulin gene (INS-DRIP). Clinical parameters were collected retrospectively. Results Of 80 individuals, 67 had proliferation responses to one or more islet antigens, with vast differences in the extent of proliferation. Based on the multitude and amplitude of the proliferation responses, individuals were clustered into non-, intermediate and high responders. High responders could not be characterised entirely by enrichment for the highest risk HLA-DR3-DQ2/DR4-DQ8 genotype. However, high responders did have a significantly higher non-HLA GRS. Clinically, high T cell responses to beta cell antigens did not reflect in worsened glycaemic control, increased complications, development of associated autoimmunity or younger age at disease onset. The number of beta cell antigens that an individual responded to increased with disease duration, pointing to chronic islet autoimmunity and epitope spreading. Conclusions/interpretation Collectively, these data provide new insights into type 1 diabetes disease heterogeneity and highlight the importance of stratifying patients on the basis of their genetic and autoimmune signatures for immunotherapy and personalised disease management.
引用
收藏
页码:351 / 361
页数:11
相关论文
共 50 条
  • [31] Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis
    Jonsdottir, Berglind
    Larsson, Christer
    Carlsson, Annelie
    Forsander, Gun
    Ivarsson, Sten Anders
    Lernmark, Ake
    Ludvigsson, Johnny
    Marcus, Claude
    Samuelsson, Ulf
    Ortqvist, Eva
    Larsson, Helena Elding
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (04) : 1277 - 1285
  • [32] Autoimmune disorders associated with type 1 diabetes: clinical overview and principles of management
    Sobolewska, Joanna
    Zak, Zuzanna
    Dzialach, Lukasz
    Witek, Przemyslaw
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2023, 19 (04): : 295 - 304
  • [33] Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering
    Mistry, Sejal
    Gouripeddi, Ramkiran
    Raman, Vandana
    Facelli, Julio C.
    DIABETOLOGIA, 2023, 66 (03) : 520 - 534
  • [34] Genetic Susceptibility in Type 1 Diabetes and its Associated Autoimmune Disorders
    Akane Ide
    George S. Eisenbarth
    Reviews in Endocrine and Metabolic Disorders, 2003, 4 : 243 - 253
  • [35] Clinical and research uses of genetic risk scores in type 1 diabetes
    Sharp, Seth A.
    Weedon, Michael N.
    Hagopian, William A.
    Oram, Richard A.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2018, 50 : 96 - 102
  • [36] Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders
    Ide, A
    Eisenbarth, GS
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2003, 4 (03) : 243 - 253
  • [37] Islet inflammation and CXCL10 in recent-onset type 1 diabetes
    Roep, B. O.
    Kleijwegt, F. S.
    van Halteren, A. G. S.
    Bonato, V.
    Boggi, U.
    Vendrame, F.
    Marchetti, P.
    Dotta, F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 159 (03) : 338 - 343
  • [38] Progress in Understanding Type 1 Diabetes Through Its Genetic Overlap with Other Autoimmune Diseases
    Roizen, Jeffrey D.
    Bradfield, Jonathan P.
    Hakonarson, Hakon
    CURRENT DIABETES REPORTS, 2015, 15 (11)
  • [39] Risk factors associated with the development of retinopathy 10yr after the diagnosis of juvenile-onset type 1 diabetes in Taiwan: a cohort study from the CGJDES
    Wang, Nan-Kai
    Lai, Chi-Chun
    Wang, Jung-Pan
    Wu, Wei-Chi
    Liu, Laura
    Yeh, Lung-Kun
    Tseng, Hsiao-Jung
    Chang, Chee-Jen
    Lo, Fu-Sung
    PEDIATRIC DIABETES, 2016, 17 (06) : 407 - 416
  • [40] Risk Factors Associated With the Development of Nephropathy 10 Years After Diagnosis in Taiwanese Children With Juvenile-Onset Type 1 Diabetes - A Cohort Study From the CGJDES
    Yang, Ching-Chien
    Lin, Chia-Hung
    Wang, Nan-Kai
    Lai, Chi-Chun
    Lo, Fu-Sung
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9